Literature DB >> 3810038

Two allotypes of factor IX present in haemophilia B.

R Ljung, A Wallmark, I M Nilsson.   

Abstract

Factor IX antigen (IX:Ag) was measured with three different immunoradiometric assays (IRMAs) in 30 healthy people and 43 patients with haemophilia B of varying severity. Two of the IRMAs were based on monoclonal antibodies capable of differentiating between two genetically determined molecular variants of normal factor IX. Most patients with severe hemophilia B lacked demonstrable IX:Ag. The factor IX variant that is undetectable with one of the monoclonal antibodies used was present in 2 out of 6 families with moderate haemophilia B and in 1 out of 6 families with mild haemophilia B. The existence of allotypes of factor IX in hemophilia B may have practical implications for carrier detection and prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3810038     DOI: 10.1111/j.1600-0609.1986.tb02629.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  2 in total

1.  The Malmö polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F.IX polymorphisms.

Authors:  J B Graham; D B Lubahn; S T Lord; J Kirshtein; I M Nilsson; A Wallmark; R Ljung; L D Frazier; J L Ware; S W Lin
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

2.  Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph.

Authors:  Dougald M Monroe; Richard J Jenny; Kevin E Van Cott; Shelly Buhay; Laura L Saward
Journal:  Adv Hematol       Date:  2016-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.